SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-22-000776
Filing Date
2022-03-31
Accepted
2022-03-31 16:48:41
Documents
52
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20211231x10k.htm   iXBRL 10-K 1498870
2 EX-4.5 tmb-20211231xex4d5.htm EX-4.5 111210
3 EX-31.1 tmb-20211231xex31d1.htm EX-31.1 12738
4 EX-31.2 tmb-20211231xex31d2.htm EX-31.2 12024
5 EX-32.1 tmb-20211231xex32d1.htm EX-32.1 7222
6 EX-32.2 tmb-20211231xex32d2.htm EX-32.2 7337
  Complete submission text file 0001410578-22-000776.txt   5395302

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20211231.xsd EX-101.SCH 44511
8 EX-101.CAL tmb-20211231_cal.xml EX-101.CAL 24369
9 EX-101.DEF tmb-20211231_def.xml EX-101.DEF 205892
10 EX-101.LAB tmb-20211231_lab.xml EX-101.LAB 338375
11 EX-101.PRE tmb-20211231_pre.xml EX-101.PRE 287358
46 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20211231x10k_htm.xml XML 626748
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Filer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-40119 | Film No.: 22793542
SIC: 6770 Blank Checks
Office of Real Estate & Construction